Literature DB >> 24131907

Cutaneous manifestations of antiphospholipid syndrome: a review of the clinical features, diagnosis and management.

Teresa Pinto-Almeida, Mónica Caetano, Madalena Sanches, Manuela Selores.   

Abstract

Antiphospholipid syndrome is a relatively recent systemic autoimmune disorder defined by thrombotic events and/or obstetric complications in the presence of persistent elevated antiphospholipid antibodies. It\'s characterized by a wide spectrum of clinical presentations and virtually any organ system or tissue may be affected by the consequences of vascular occlusion. Diagnosis is sometimes difficult and although classification criteria have been published and revised there remain ongoing issues regarding nomenclature, expanding clinical features, laboratory tests and management and much still has to be done. Cutaneous manifestations are common and frequently the first sign of the disease. Although extremely diverse it\'s important to know which dermatological findings should prompt consideration of antiphospholipid syndrome and the appropriate management for those patients. Much has been debated about when to consider antiphospholipid syndrome and consensus still does not exist, however in spite of being a diagnostic challenge clinicians should know when to look for antiphospholipid antibodies since an early diagnosis is important to prevent further and serious complications. In this article we focus on the cutaneous features that should raise suspicion on the presence of antiphospholipid syndrome and on the complex management of such patients. Many other dermatological signs related to this syndrome have been described in the literature but only occasionally and without consistency or statistic impact and therefore will not be considered here.

Entities:  

Mesh:

Year:  2013        PMID: 24131907

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  4 in total

Review 1.  The antiphospholipid syndrome: from pathophysiology to treatment.

Authors:  Simone Negrini; Fabrizio Pappalardo; Giuseppe Murdaca; Francesco Indiveri; Francesco Puppo
Journal:  Clin Exp Med       Date:  2016-06-22       Impact factor: 3.984

Review 2.  Pigmented purpura and cutaneous vascular occlusion syndromes.

Authors:  Ana Cecilia Lamadrid-Zertuche; Verónica Garza-Rodríguez; Jorge de Jesús Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

3.  An atypical presentation of antiphospholipid antibody syndrome.

Authors:  Deepti D'souza; Sukumar Dandakeri; M Ramesh Bhat; M K Srinath
Journal:  Indian Dermatol Online J       Date:  2015 Jul-Aug

4.  Purpura fulminans-like lesions in antiphospholipid syndrome with endothelial C3 deposition.

Authors:  Jorge Magdaleno-Tapial; Cristian Valenzuela-Oñate; Javier Pitarch-Fabregat; María Marín-Jiménez; Clara Molina Almela; Johana Isidora Gutiérrez-Salcedo; Javier Calvo-Catalá; José Luis Sánchez-Carazo; V Alegre-de Miquel
Journal:  JAAD Case Rep       Date:  2018-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.